Ubujipam is a new oral calcitonin gene-related peptide receptor (CGRP) antagonist, which has the potential to be used in the study of acute migraine.
Synonymous | piro[6H-cyclopenta[b]pyridine-6,3'-[3H]pyrrolo[2,3-b]pyridine]-3-carboxamide;1',2',5,7-tetrahydro-N-[(3S,5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)-3-piperidinyl]-2'-oxo-, (3'S)- |
Structure | |
CAS | 1374248-77-7 |
Molecular Formula | C29H26F3N5O3 |
Molecular Weight | 549.54 |
Appearance | White powder |
Packing | 25kg cardboard barrel |
Uses | Pharmaceutical intermediates; Study on acute migraine |
Storage | Dark and dry |